Distribution of breast density in Iranian women and its association with breast cancer risk factors

Iranian Red Crescent Medical Journal

Volumn 15, Issue 12, 2013, Pages

  Ahmadinejad, Nasrin ^a   Movahedinia, Sajjadeh ^b   Movahedinia, Samaneh ^b   Naieni, Kourosh Holakouie ^c   Nedjat, Saharnaz ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast neoplasms; Mammography; Mass screening

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST DENSITY; BREAST FEEDING; CANCER RISK; CANCER SCREENING; CROSS-SECTIONAL STUDY; DENSITY; EMPLOYMENT STATUS; FEMALE; FEMALE BY MARITAL STATUS; HORMONE SUBSTITUTION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; ORAL CONTRACEPTION; OVARY CYCLE; PARITY; QUESTIONNAIRE; RISK FACTOR; SMOKING; VERY ELDERLY;

EID: 84890867596     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.16615     Document Type: Article

References (43)

1. World Health Organization. 2013. Available from: http://www. who.int/mediacentre/factsheets/fs297/en/.
2. Boyle P, Levin B. France: World Health Organization; 2008.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Cli. 2005;55(2):74-108.
4. Wilson CM, Tobin S, Young RC. The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cance. 2004;14(1):1-11.
5. Goya M. Tehran, Iran; 2007.
6. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Onco. 2009;20(3):556-63.
7. Pu L, Jing S, Bianqin G, Ping L, Qindong L, Chenggui L, et al. Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma. Hepat Mo. 2013;13(7).
8. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Pre. 2004;5(1):24-7.
9. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast. 2007;13(4):383-91.
10. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Healt. 2000;114(2):143-5.
11. Moradi M, Ganji K, Teyfouri N, Kolahdoozan F. Performance of double reading mammography in an Iranian population and its effect on patient outcome. Iran J Radio. 2013;10(2):51-5.
12. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAM. 2005;293(10):1245-56.
13. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Ins. 1995;87(9):670-5.
14. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Ins. 1995;87(21):1622-9.
15. McCormack VA, Highnam R, Perry N, dos Santos Silva I. Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Pre. 2007;16(6):1148-54.
16. Nadrljanski MM, MarkoviÄ BB, MiloÅeviÄ ZÄ. Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings. Iran J Radio. 2013;10(2):99-102.
17. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgeno. 1987;148(6):1087-92.
18. Farrokh D, Hashemi J, Ansaripour E. Breast hamartoma: mammographic findings. Iran J Radio. 2011;8(4):258-60.
19. Nawawi O, Ying Goh K, Rahmat K. A rare case of primary infiltrating neuroendocrine carcinoma of the breast. Iran J Radio. 2012;9(4):212-6.
20. Azarian A, Mohammadifard M. Analysis of the Factors, Effective on Breast Parenchymal Density in Mammogram. Iran J Obste. 2008;11(1):9-16.
21. Sirus M, Golshahi Z, Talayi S, Oshaghi F. Correlation of Asymmetric Breast Density Findings in Mammograms with Cytologic Findings. Iran J Radio. 2005;3(S1):1-2.
22. Silanian F. The effect of HRT on sensitivity of screening mammographic in menopause women. Mazandaran University Med. 2004;14(42):76-83.
23. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Ins. 2007;99(5):386-95.
24. Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Contro. 2006;17(10):1281-90.
25. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgeno. 1998;171(1):35-40.
26. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M. Mammographic densities and risk of breast cancer. Cancer Causes Contro. 1991;67(11):2833-38.
27. Yu-Mei L, Hsueh-Hua Y. Demographic Factors Influencing Consensus Opinion on the Recall for Women Screened by Mobile Mammography Unit in Taiwan. Iran J Radio. 2013;10(3):116-121.
28. Marinelli S, Granito A, Piscaglia F, Renzulli M, Stagni A, Bolondi L. Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases. Hepat Mo. 2013;13(9).
29. Sanjari S, Naderifar A, Pazuki G. Modeling and Optimization of β-Cyclodextrin Production by Bacillus licheniformis using Artifi{ligature}cial Neural Network and Genetic Algorithm. Iran J Biotec. 2013;11(4):223-232.
30. Modugno F, Ngo DL, Allen GO, Kuller LH, Ness RB, Vogel VG, et al. Breast cancer risk factors and mammographic breast density in women over age 70. Breast Cancer Res Trea. 2006;97(2):157-66.
31. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Contro. 2000;11(7):653-62.
32. Nadrljanski MM, MarkoviÄ BB, MiloÅeviÄ ZÄ. Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings. Iran J Radio. 2013;10(2):99-102.
33. Aras M, Ones T, Dane F, Nosheri O, Inanir S, Erdil TY, et al. False Positive FDG PET/CT Resulting from Fibrous Dysplasia of the Bone in the Work-Up of a Patient with Bladder Cancer: Case Report and Review of the Literature. Iran J Radio. 2013;10(1):41-44.
34. Moradi M, Ganji K, Teyfouri N, Kolahdoozan F. Performance of Double Reading Mammography in an Iranian Population and Its Effect on Patient Outcome. Iran J Radio. 2013;10(2):51-5.
35. Dadashpour Davachi N, Miri SM. Embryo Culture Challenge: Microbial Contamination. Iran J Biotec. 2013;11(4):207-208.
36. Zeinoaldini S, Jafari Z, Sarmast F, Torbati E, Dadashpour Davachi N. Different Harvesting Techniques Used in Ovine in vitro Embryo Production. Scimet. 2013;1(1).
37. Rahmani MM, Shakiba B, Ameli M. Management of an Extremely Long Foreign Body in the Urethra and Bladder of a 13-Year-old boy: A Case Report. Thrit. 2013;2(1):35-37.
38. Sabzi Sarvestani A, Zamiri M. Presacral Schwannoma Causing Infertility in a Young Woman: Report of a Case. Scimet. 2013;1(1).
39. Khazan M, Azizi F, Hedayati M. A Review on Iodine Determination Methods in Salt and Biological Samples. Scimet. 2013;1(1).
40. Valadkhani Z, Hassan N, Aghighi Z. A Survey Study of Trichomonas Vaginalis Infection in Unmarried Male Referred to Farmanfarmaean Clinic. Scimet. 2013;1(1).
41. Fayaz S, Fard-Esfahani P, Khaghani S. Development of a High-Resolution Melting Method for Screening R188H Polymorphism in XRCC2 Gene. Iran J Biotec. 2013;11(2):104-8.
42. Trinh DK, Quyen DT, Do TT, Huong Nguyen TT, Nghiem NM. Optimization of Culture Conditions and Medium Components for Carboxymethyl Cellulase (CMCase) Production by a Novel Basidiomycete Strain Peniophora sp. NDVN01. Iran J Biotec. 2013;11(4):251-259.
43. Zheng Y, Zhang S, Tan Grahn HM, Ye C, Gong Z, Zhang Q. Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis. Hepat Mo. 2013;13(4).